Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELABELA exposure in donated human embryos to assess induction of monozygotic twinning
NL-OMON46173Withdrawn
- Sponsor
- Vrije University Medical Center
- Start
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Open-label trial of elabela (2 arms), sponsored by Vrije University Medical Center. Planned start Jan 2019; status: withdrawn.
02
Drugs
elabela
Beyond the preview
Go deeper on NL-OMON46173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46173.